Relationship Between Risk Factors and Macular Thickness in Patients with Early Diabetic Retinopathy

被引:5
作者
Wei, Qingquan [1 ]
Qiu, Wei [1 ]
Liu, Qing [1 ,2 ]
Jiang, Yanyun [1 ]
机构
[1] Shanghai Jiao Tong Univ, Tong Ren Hosp, Sch Med, Dept Ophthalmol, Shanghai 200336, Peoples R China
[2] Shanghai Key Lab Ocular Fundus Dis, Shanghai 200080, Peoples R China
关键词
diabetic retinopathy; macular thickness; optical coherence tomography; risk factors; RETINAL THICKNESS; VISUAL-ACUITY; PREVALENCE; PROGRESSION; EDEMA; EYE;
D O I
10.2147/IJGM.S366348
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The purpose of this study was to explore the changes in macular thickness (MT) in normal people, patients without obvious diabetic retinopathy (NDR) and patients with nonproliferative diabetic retinopathy (NPDR) and to study the possible risk factors for Methods: Thirty-one healthy individuals, 40 people with no sign of DR and 60 people with mild NPDR were included in this crosssectional study. All patients underwent a complete ophthalmological examination. Optical coherence tomography (OCT) was used to measure the MT of each participant. The potential relationship between MT and systemic risk factors for DR, including diabetes duration, body mass index (BMI), hemoglobin A1c (HbA1c), serum lipids, and blood pressure, was analyzed. Results: The MT of the right and left eyes in the central and inner ring regions of the NPDR group and NDR group were significantly different from that in the control group. The MTs of the right and left eyes in the central region and inner ring region were also significantly different between the NPDR group and NDR group, but the MTs of the right and left eyes in the outer ring region were not significantly different among the three groups. Diabetic duration, total cholesterol (TC), triglycerides (TGs), systolic pressure, and diastolic pressure were positively correlated with the MT of the right and left eyes in the central region. Conclusion: MT increases, especially in the central region and inner ring, may be the first structural retinal change in diabetic patients and is related to the duration of diabetes, TC, TG, systolic pressure and diastolic pressure.
引用
收藏
页码:6021 / 6029
页数:9
相关论文
共 38 条
[1]   Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial [J].
Beulens, J. W. J. ;
Patel, A. ;
Vingerling, J. R. ;
Cruickshank, J. K. ;
Hughes, A. D. ;
Stanton, A. ;
Lu, J. ;
Thom, S. A. McG ;
Grobbee, D. E. ;
Stolk, R. P. .
DIABETOLOGIA, 2009, 52 (10) :2027-2036
[2]   Diabetic Macular Edema: Pathogenesis and Treatment [J].
Bhagat, Neelakshi ;
Grigorian, Ruben A. ;
Tutela, Arthur ;
Zarbin, Marco A. .
SURVEY OF OPHTHALMOLOGY, 2009, 54 (01) :1-32
[3]   Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment A Secondary Analysis of a Randomized Clinical Trial [J].
Bressler, Neil M. ;
Beaulieu, Wesley T. ;
Glassman, Adam R. ;
Blinder, Kevin J. ;
Bressler, Susan B. ;
Jampol, Lee M. ;
Melia, Michele ;
Wells, John A., III .
JAMA OPHTHALMOLOGY, 2018, 136 (03) :257-269
[4]  
Bressler SB, 2019, JAMA OPHTHALMOL, V137, P382, DOI 10.1001/jamaophthalmol.2018.6786
[5]   The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema [J].
Browning, David J. ;
Fraser, Christina M. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (01) :149-154
[6]   Evaluation of morphological characteristics of diabetic macular edema in patients with non-proliferative versus proliferative diabetic retinopathy: a spectral-domain optical coherence tomography study [J].
Chatziralli, Irini ;
Theodossiadis, George ;
Dimitriou, Eleni ;
Theodossiadis, Panagiotis .
INTERNATIONAL OPHTHALMOLOGY, 2021, 41 (07) :2417-2424
[7]   Diabetic retinopathy [J].
Cheung, Ning ;
Mitchell, Paul ;
Wong, Tien Yin .
LANCET, 2010, 376 (9735) :124-136
[8]   Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study [J].
Chew, Emily Y. ;
Lovato, James F. ;
Davis, Matthew D. ;
Gerstein, Hertzel C. ;
Danis, Ronald P. ;
Ismail-Beigi, Faramarz ;
Genuth, Saul ;
Greven, Craig M. ;
Perdue, Letitia H. ;
Cushman, William C. ;
Elam, Marshall B. ;
Bigger, J. Thomas ;
Ginsberg, Henry N. ;
Goff, David C., Jr. ;
Ambrosius, Walter T. .
DIABETES CARE, 2016, 39 (07) :1089-1100
[9]   Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes. [J].
Chew, Emily Y. ;
Ambrosius, Walter T. ;
Davis, Matthew D. ;
Danis, Ronald P. ;
Gangaputra, Sapna ;
Greven, Craig M. ;
Hubbard, Larry ;
Esser, Barbara A. ;
Lovato, James F. ;
Perdue, Letitia H. ;
Goff, David C., Jr. ;
Cushman, William C. ;
Ginsberg, Henry N. ;
Elam, Marshall B. ;
Genuth, Saul ;
Gerstein, Hertzel C. ;
Schubart, Ulrich ;
Fine, Lawrence J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (03) :233-244
[10]   Neurodegeneration in Type 2 Diabetes: Evidence From Spectral-Domain Optical Coherence Tomography [J].
Chhablani, Jay ;
Sharma, Apoorva ;
Goud, Abhilash ;
Peguda, Hari Kumar ;
Rao, Harsha L. ;
Begum, Viquar Unnisa ;
Barteselli, Giulio .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (11) :6333-6338